PAYS · Paysign, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-16 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $8.87, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
28,000 |
| 2026-07-15 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.71, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
31,904 |
| 2026-06-26 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0071 to $8.0329, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
100,000 |
| 2026-06-01 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0001 to $8.0200, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
29,202 |
| 2026-05-29 | Baker Jeffery Bradford |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
44,541 |
| 2026-05-27 | Strobo Robert |
Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
39,235 |
| 2026-05-26 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0001 to $7.0249, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
22,534 |
| 2026-05-20 | Newcomer Mark |
Director, CEO, 10% Owner |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
78,701 |
| 2026-05-18 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
12,755 |
| 2026-05-13 | Herman Joan M |
Director, EVP, Operations |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock. |
Common Stock
|
6,171 |
| 2026-05-04 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.001 to $7.0203, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
6,667 |
| 2026-02-28 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the February 28, 2021 vesting commencement date until fully vested on February 28, 2026. |
Stock Grant
|
60,000 |
| 2026-02-28 | Baker Jeffery Bradford |
Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock units. |
Common Stock
|
26,055 |
| 2026-02-28 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the February 28, 2021 vesting commencement date until fully vested on February 28, 2026. |
Common Stock
|
60,000 |
| 2025-12-12 | Strobo Robert |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2025. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.4601 to $5.4701, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
20,000 |
| 2025-11-13 | Baker Jeffery Bradford |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 29, 2026, May 20, 2027, and May 30, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
200,000 |
| 2025-11-13 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 18, 2026, May 18, 2027, and May 18, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
66,666 |
| 2025-11-13 | Strobo Robert |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 27, 2026, May 24, 2027, and May 26, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
200,000 |
| 2025-11-13 | Newcomer Mark |
Director, CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 20, 2026, May 28, 2027, and May 22, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
400,000 |
| 2025-11-13 | Herman Joan M |
Director, EVP, Operations |
Award↑
Filing footnotes — Common Stock (Direct)
Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 13, 2026, May 13, 2027, and May 13, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
33,333 |
| 2025-08-04 | Herman Joan M |
Director, EVP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
14,160 |
| 2025-08-04 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
62,158 |
| 2025-08-04 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
26,367 |
| 2025-08-04 | Strobo Robert |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
26,521 |
| 2025-08-04 | Baker Jeffery Bradford |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
30,396 |
| 2025-07-31 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2025-07-31 | Herman Joan M |
Director, EVP, Operations |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
36,000 |
| 2025-07-31 | Strobo Robert |
Chief Legal Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2025-07-31 | Strobo Robert |
Chief Legal Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2025-07-31 | Baker Jeffery Bradford |
Chief Financial Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2025-07-31 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
64,000 |
| 2025-07-31 | Newcomer Mark |
Director, CEO, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Common Stock
|
150,000 |
| 2025-07-31 | Lanford Matthew Louis |
Director, Chief Payments Officer |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
64,000 |
| 2025-07-31 | Herman Joan M |
Director, EVP, Operations |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
36,000 |
| 2025-07-31 | Newcomer Mark |
Director, CEO, 10% Owner |
Convert↓
Filing footnotes — Stock Grant (Direct)
One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. |
Stock Grant
|
150,000 |
| 2025-06-16 | HENRY DANIEL R |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9385 to $4.99, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares pourcased at each separate price within the range set forth in this footnote. |
Common Stock
|
10,084 |
| 2025-06-11 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0001, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
8,000 |
| 2025-06-10 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.01, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
31,500 |
| 2025-06-09 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0101, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote |
Common Stock
|
46,500 |
| 2025-06-05 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. |
Common Stock
|
19,693 |
| 2025-06-02 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. |
Common Stock
|
307 |
| 2025-05-31 | Mina Bruce A |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On September 11, 2024, the reporting person received a grant of 20,000 shares of common stock vesting on May 31, 2025. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2025-05-31 | NEWMAN JEFFREY B |
Exec VP and General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
On September 11, 2024, the reporting person received a grant of 20,000 shares of common stock vesting on May 31, 2025. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2025-05-31 | Triplett Dennis L |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On September 11, 2024, the reporting person received a grant of 20,000 shares of common stock vesting on May 31, 2025. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2025-05-31 | HENRY DANIEL R |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On September 11, 2024, the reporting person received a grant of 20,000 shares of common stock vesting on May 31, 2025. As of the date of this filing, 20,000 shares of common stock have vested. |
Common Stock
|
20,000 |
| 2025-05-29 | Newcomer Mark |
Director, CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.5 to $4.5401, inclusive. The reporting person undertakes to provide Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
168,000 |
| 2025-05-14 | HENRY DANIEL R |
Director |
Buy↑
|
Common Stock
|
19,800 |
| 2025-05-07 | Baker Jeffery Bradford |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock that will vest as to 1/3 of the shares on each of May 29, 2026, May 20, 2027 and May 30, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
100,000 |
| 2025-05-07 | Strobo Robert |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock that will vest as to 1/3 of the shares on each of May 27, 2026, May 24, 2027 and May 26, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
100,000 |
| 2025-05-07 | Newcomer Mark |
Director, CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares of restricted stock that will vest as to 1/3 of the shares on each of May 27, 2026, May 24, 2027 and May 26, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date. |
Common Stock
|
200,000 |